Day One Biopharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DAWN Nasdaq 2836 dayonebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Day One Biopharmaceuticals, Inc.

When Will Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Breakeven? - Jun 30th, 2025 4:51 am
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development - Jun 10th, 2025 6:30 am
We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth - May 20th, 2025 4:11 am
Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now? - May 13th, 2025 8:47 am
Is Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030? - May 9th, 2025 5:54 am
Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - May 7th, 2025 1:21 am
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates - May 6th, 2025 3:25 pm
Day One Reports First Quarter 2025 Financial Results and Corporate Progress - May 6th, 2025 2:01 pm
Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025 - Apr 22nd, 2025 6:30 am
Exploring US High Growth Tech Stocks This April 2025 - Apr 9th, 2025 11:38 am
Day One Biopharmaceuticals, Inc. (DAWN): Among Stocks Under $10 that Will Triple - Apr 9th, 2025 7:44 am
High Growth Tech Stocks In The US With Promising Potential - Mar 10th, 2025 11:08 am
Day One Biopharmaceuticals, Inc. (DAWN): A Bull Case Theory - Mar 5th, 2025 7:00 am
Jazz Stock Gains as Q4 Earnings & Sales Surpass Expectations - Feb 26th, 2025 5:49 am
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Tops Revenue Estimates - Feb 25th, 2025 3:55 pm
Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress - Feb 25th, 2025 2:05 pm
Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates - Feb 21st, 2025 6:38 am
Does Day One Biopharmaceuticals (DAWN) Have the Potential to Rally 193.16% as Wall Street Analysts Expect? - Feb 13th, 2025 7:55 am
New Strong Buy Stocks for February 13th - Feb 13th, 2025 2:51 am
Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025 - Feb 11th, 2025 6:30 am